Company news
Liminal BioSciences Inc news in 2020
Liminal BioSciences Inc's news releases, calls and decks from 2020, newest first.
Liminal BioSciences to Voluntarily Delist from the Toronto Stock Exchange
July 22, 2020
Liminal BioSciences Broadens R&D Pipeline With Novel Preclinical Program For Eosinophilic-Driven Diseases
July 17, 2020
Liminal BioSciences Joins CoVIg Plasma Alliance to Contribute to Development of Potential New COVID-19 Therapy
July 2, 2020
Liminal BioSciences Commences Collection of Convalescent Plasma from COVID-19 Recovered Donors
June 30, 2020
Liminal BioSciences Provides Guidance Update on Certain Expected Key Milestones For 2020
June 30, 2020
Liminal BioSciences to Present at Raymond James Human Health Innovation Conference
June 11, 2020
Liminal Announces Voting Results of Its 2020 Annual And Special General Meeting Of Shareholders (AGM)
June 9, 2020
Liminal BioSciences to present at Jefferies Virtual Healthcare Conference
May 28, 2020
Liminal Biosciences Reports Q1 2020 Results
May 13, 2020
Liminal BioSciences comments on Coronavirus (COVID-19)
March 22, 2020
Liminal Biosciences Reports Fourth Quarter and 2019 Year End Results
March 20, 2020
Liminal BioSciences to report its fourth quarter and year-end 2019 financial results and hold conference call/webcast
March 20, 2020
Liminal BioSciences Announces Scientific Presentations at Upcoming Keystone Symposia
February 12, 2020
Liminal BioSciences announces upcoming investor presentation at BIO CEO & Investor Conference
February 6, 2020
Liminal BioSciences Outlines Corporate Priorities for 2020
January 13, 2020